Rare diseases
Investigational molecules
Locations
2 Redman Place, E20 1JQ, United Kingdom
Clinical research activity is centred on metastatic pancreatic ductal adenocarcinoma, with interest in the treatment of advanced pancreatic cancer and tumour control in late-stage disease.
Research focuses on combination treatment strategies involving gemcitabine, nab-paclitaxel, and maintenance use of cobimetinib alongside an investigational monoclonal antibody.
Cancer Research UK runs clinical trials in conditions such as Adrenocortical carcinoma, Pancreatic carcinoma metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
